ENETS Abstract Search

PRRT for Malignant Pheochromocytomas and Paragangliomas: The Singapore General Hospital Experience

#1305

Introduction: In recent years, the use of 177Lu-DOTATATE radioisotope therapy has been expanded to patients with metastatic pheochromocytomas and paragangliomas (PCC/PGL). Although this is not the standard of care, treatment options are limited for those with MIBG negative disease. Our centre has treated over 40 patients with NETS with PRRT since 2012.

Aim(s): We share our clinical experience of PRRT in 4 patients with functional metastatic PCC/PGL.

Materials and methods: Three PGL patients and 1 PCC patient have undergone PRRT since 2014.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Loh L, Lim D, Loke K, Ng D,

Keywords: PRRT, pheochromocytoma, paraganglioma,

To read the full abstract, please log into your ENETS Member account.